phosphagenics collaborates with 3m to develop , page-35

Ggjj, The trials are planned to be done conjointly, starting Phase two and running continuously thru stage 3.

same patients are to continue both trials. they are expected to be finished 12 months from now. They are not long trials.

The two aims are to prove their is no Skin irritation or toxology whilst maintaining therapeutic blood levels.

the 3m patches are expected to be of far superior performance than than HOME MADE patches used in previous trials. We already know 24 hour therapeutic levels are easily attained without any skin toxology.

it is really a matter of collecting data for FDA approval and testing 3M made commercial patches to prove 7 day efficacy.That is such a huge money spinner if achieved.

The company is very confidant as they have a huge amount of knowledge about how TPM performs.

This is getting to be a very safe bet fro a product with such a big market appeal.

poS